Percutaneous mitoxantrone injection for primary and secondary liver tumors: preliminary results.
- 1 September 1998
- journal article
- clinical trial
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 21 (5) , 399-403
- https://doi.org/10.1007/s002709900287
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbitsCancer Chemotherapy and Pharmacology, 1996
- Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.Radiology, 1996
- Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.Radiology, 1995
- Primary liver cancersCurrent Opinion in Oncology, 1995
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Subcellular localisation of the antitumour drug mitoxantrone and the induction of DNA damage in resistant and sensitive human colon carcinoma cellsCancer Chemotherapy and Pharmacology, 1995
- Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients.American Journal of Roentgenology, 1993
- Evidence for Persistence of Mitoxantrone within the Peritoneal Cavity Following Intraperitoneal DeliveryGynecologic Oncology, 1993
- Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization.Radiology, 1992
- Liver metastases: results of percutaneous ethanol injection in 14 patients.Radiology, 1991